TickerFactsScreenerDevelopers

Vanda Pharmaceuticals Inc. (VNDA) — Revenue

Annual figures by fiscal year, from SEC filings.

2011: $31.27M2012: $32.73M2013: $33.88M2014: $50.16M2015: $109.92M2016: $146.02M2017: $165.08M2018: $193.12M2019: $227.19M2020: $248.17M2021: $268.68M2022: $254.38M2023: $192.64M2024: $198.77M2025: $216.10M$216.10M
2011Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$216.10M+8.7%
2024$198.77M+3.2%
2023$192.64M-24.3%
2022$254.38M-5.3%
2021$268.68M+8.3%
2020$248.17M+9.2%
2019$227.19M+17.6%
2018$193.12M+17.0%
2017$165.08M+13.1%
2016$146.02M+32.8%
2015$109.92M+119.2%
2014$50.16M+48.0%
2013$33.88M+3.5%
2012$32.73M+4.7%
2011$31.27M—